Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial)

SIMPLE SUMMARY: Nowadays, the surgery of liver metastases remains the only hope of a cure for patients with colorectal cancer. Pathological responses evaluated after preoperative treatment strongly influences the risk of relapse and patient survival. Previous studies reported that preoperative bevac...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldin, Pamela, Carrasco, Javier, Beniuga, Gabriela, Jouret-Mourin, Anne, Demolin, Gauthier, Roland, Sandrine, D’Hondt, Lionel, Vergauwe, Philippe, Van Daele, Daniel, Mailleux, Marie, Sinapi, Isabelle, De Cuyper, Astrid, Blétard, Noëlla, Massart, Brigitte, Delos, Monique, Castella, Marie-Laure, van Maanen, Aline, Van den Eynde, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909786/
https://www.ncbi.nlm.nih.gov/pubmed/35267491
http://dx.doi.org/10.3390/cancers14051183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909786/
https://www.ncbi.nlm.nih.gov/pubmed/35267491
http://dx.doi.org/10.3390/cancers14051183

Ejemplares similares